Article contents
Recombinant activated factor VII to control massive post operative bleeding after septic aortobifemoral grafting
Published online by Cambridge University Press: 15 September 2005
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Correspondence
- Information
- Copyright
- © 2005 European Society of Anaesthesiology
References
Roberts HR, Monroe DM, Escobar MA. Current concepts of hemostasis: implications for therapy. Anesthesiology 2004; 100: 722–730.Google Scholar
Martinowitz U, Kenet G, Segal E et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001; 51: 431–438; discussion 438–439.Google Scholar
Godet G, Samama CM, Ankri A et al. [Mechanisms and prediction of hemorrhagic complications during surgery of thoraco-abdominal aortic aneurysms.] Ann Fr Anesth Reanim 1990; 9: 415–422.Google Scholar
Cohen JR, Angus L, Asher A, Chang JB, Wise L. Disseminated intravascular coagulation as a result of supraceliac clamping: implications for thoracoabdominal aneurysm repair. Ann Vasc Surg 1987; 1: 552–557.Google Scholar
Erhardtsen E. Pharmacokinetics of recombinant activated factor VII (rFVIIa). Semin Thromb Hemost 2000; 26: 385–391.Google Scholar
Weiskopf RB. Intraoperative use of recombinant activated coagulation factor VII. Anesthesiology 2002; 96: 1287–1289.Google Scholar
Dutton RP, Hess JR, Scalea TM. Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients. J Clin Anesth 2003; 15: 184–188.Google Scholar
- 5
- Cited by